<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font18">and </span>
   <span class="font13">for </span>
   <span class="font12">with </span>
   <span class="font12">that </span>
   <span class="font11">European </span>
   <span class="font11">The </span>
   <span class="font11">IRN </span>
   <span class="font11">was </span>
   <span class="font11">are </span>
   <span class="font11">from </span>
   <span class="font11">public </span>
   <span class="font11">Medicines </span>
   <span class="font11">{background </span>
   <span class="font11">EUâ€�IMP </span>
   <span class="font11">regulatory </span>
   <span class="font10">Accessed </span>
   <span class="font10">communication </span>
   <span class="font10">information </span>
   <span class="font10">were </span>
   <span class="font10">collab: </span>
   <span class="font10">margin </span>
   <span class="font10">Agency </span>
   <span class="font10">health </span>
   <span class="font10">issues </span>
   <span class="font10">safety </span>
   <span class="font10">{border-style </span>
   <span class="font10">[Web </span>
   <span class="font10">has </span>
   <span class="font10">page]. </span>
   <span class="font10">its </span>
   <span class="font10">may </span>
   <span class="font10">px;} </span>
   <span class="font10">through </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">have </span>
   <span class="font10">incidents </span>
   <span class="font10">initial </span>
   <span class="font10">products </span>
   <span class="font10">issue </span>
   <span class="font10">medicinal </span>
   <span class="font10">medicines </span>
   <span class="font10">quality </span>
   <span class="font10">November </span>
   <span class="font10">authorized </span>
   <span class="font10">impact </span>
   <span class="font10">pharmacovigilance </span>
   <span class="font10">scientific </span>
   <span class="font10">which </span>
   <span class="font10">within </span>
   <span class="font10">Network </span>
   <span class="font10">This </span>
   <span class="font10">actions </span>
   <span class="font10">after </span>
   <span class="font10">been </span>
   <span class="font10">management </span>
   <span class="font10">new </span>
   <span class="font10">other </span>
   <span class="font10">their </span>
   <span class="font10">this </span>
   <span class="font10">while </span>
   <span class="font10">EMA </span>
   <span class="font10">incident </span>
   <span class="font10">more </span>
   <span class="font10">most </span>
   <span class="font10">number </span>
   <span class="font10">referral </span>
   <span class="font10">risk </span>
   <span class="font10">FIGURE </span>
   <span class="font10">assessment </span>
   <span class="font10">measures </span>
   <span class="font10">notification </span>
   <span class="font10">routine </span>
   <span class="font10">â€‰years </span>
   <span class="font10">For </span>
   <span class="font10">appropriate </span>
   <span class="font10">due </span>
   <span class="font10">first </span>
   <span class="font10">network </span>
   <span class="font10">not </span>
   <span class="font10">product </span>
   <span class="font10">recommended </span>
   <span class="font10">system </span>
   <span class="font10">(%) </span>
   <span class="font10">Drug </span>
   <span class="font10">EMA, </span>
   <span class="font10">Figure </span>
   <span class="font10">available </span>
   <span class="font10">can </span>
   <span class="font10">include </span>
   <span class="font10">one </span>
   <span class="font10">period </span>
   <span class="font10">potential </span>
   <span class="font10">px; </span>
   <span class="font10">review </span>
   <span class="font10">well </span>
   <span class="font10">when </span>
   <span class="font10">{font-family </span>
   <span class="font10">Incident </span>
   <span class="font10">October </span>
   <span class="font10">PRAC </span>
   <span class="font10">Pharmacovigilance </span>
   <span class="font10">Regulatory </span>
   <span class="font10">address </span>
   <span class="font10">all </span>
   <span class="font10">approach </span>
   <span class="font10">article </span>
   <span class="font10">case </span>
   <span class="font10">containing </span>
   <span class="font10">decision </span>
   <span class="font10">example, </span>
   <span class="font10">expertise </span>
   <span class="font10">font-size </span>
   <span class="font10">international </span>
   <span class="font10">into </span>
   <span class="font10">medicine </span>
   <span class="font10">necessary </span>
   <span class="font10">needed </span>
   <span class="font10">possible </span>
   <span class="font10">procedure </span>
   <span class="font10">should </span>
   <span class="font10">(see </span>
   <span class="font10">Assessment </span>
   <span class="font10">During </span>
   <span class="font10">Good </span>
   <span class="font10">Union </span>
   <span class="font10">also </span>
   <span class="font10">any </span>
   <span class="font10">cases </span>
   <span class="font10">crisis. </span>
   <span class="font10">double; </span>
   <span class="font10">evidence </span>
   <span class="font10">experience </span>
   <span class="font10">issue, </span>
   <span class="font10">issue. </span>
   <span class="font10">main </span>
   <span class="font10">mainly </span>
   <span class="font10">major </span>
   <span class="font10">marketing </span>
   <span class="font10">measure </span>
   <span class="font10">need </span>
   <span class="font10">notifications </span>
   <span class="font10">plan </span>
   <span class="font10">press </span>
   <span class="font10">provided </span>
   <span class="font10">relevant </span>
   <span class="font10">serious </span>
   <span class="font10">several </span>
   <span class="font10">teleconference </span>
   <span class="font10">those </span>
   <span class="font10">triggered </span>
   <span class="font10">use </span>
   <span class="font10">;():â€�. </span>
   <span class="font10">Article </span>
   <span class="font10">EC, </span>
   <span class="font10">EPITT </span>
   <span class="font10">Human </span>
   <span class="font10">Medicinal </span>
   <span class="font10">Products </span>
   <span class="font10">Rapid </span>
   <span class="font10">Through </span>
   <span class="font10">[Colour </span>
   <span class="font10">al. </span>
   <span class="font10">analysis </span>
   <span class="font10">based </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clinical </span>
   <span class="font10">considered </span>
   <span class="font10">could </span>
   <span class="font10">crisis </span>
   <span class="font10">data </span>
   <span class="font10">different </span>
   <span class="font10">established </span>
   <span class="font10">figure </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">identification </span>
   <span class="font10">important </span>
   <span class="font10">incidents, </span>
   <span class="font10">including </span>
   <span class="font10">instance, </span>
   <span class="font10">issues. </span>
   <span class="font10">monitoring </span>
   <span class="font10">only </span>
   <span class="font10">operation </span>
   <span class="font10">options </span>
   <span class="font10">procedure, </span>
   <span class="font10">quality, </span>
   <span class="font10">regulators </span>
   <span class="font10">solid; </span>
   <span class="font10">some </span>
   <span class="font10">support </span>
   <span class="font10">taken </span>
   <span class="font10">teleconferences </span>
   <span class="font10">total </span>
   <span class="font10">used </span>
   <span class="font10">via </span>
   <span class="font10">viewed </span>
   <span class="font10">wileyonlinelibrary.com] </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(eg, </span>
   <span class="font10">(in </span>
   <span class="font10">CMDh, </span>
   <span class="font10">Clinical </span>
   <span class="font10">Committee </span>
   <span class="font10">EU, </span>
   <span class="font10">EUâ€�IMP, </span>
   <span class="font10">Health </span>
   <span class="font10">IRN. </span>
   <span class="font10">LTTs </span>
   <span class="font10">MSs </span>
   <span class="font10">Management </span>
   <span class="font10">Manufacturing </span>
   <span class="font10">Marketing </span>
   <span class="font10">NCAs </span>
   <span class="font10">PRAC, </span>
   <span class="font10">Practice </span>
   <span class="font10">RAs </span>
   <span class="font10">These </span>
   <span class="font10">across </span>
   <span class="font10">actions, </span>
   <span class="font10">adverse </span>
   <span class="font10">adâ€�hoc </span>
   <span class="font10">agreed </span>
   <span class="font10">aimed </span>
   <span class="font10">authorization </span>
   <span class="font10">authors </span>
   <span class="font10">balance </span>
   <span class="font10">bold </span>
   <span class="font10">but </span>
   <span class="font10">clear </span>
   <span class="font10">combination </span>
   <span class="font10">communication, </span>
   <span class="font10">concern </span>
   <span class="font10">concerns </span>
   <span class="font10">consideration </span>
   <span class="font10">coordinate </span>
   <span class="font10">coordination </span>
   <span class="font10">courier; </span>
   <span class="font10">dealt </span>
   <span class="font10">descriptive </span>
   <span class="font10">drug </span>
   <span class="font10">em; </span>
   <span class="font10">ensure </span>
   <span class="font10">example </span>
   <span class="font10">exchange </span>
   <span class="font10">framework </span>
   <span class="font10">further </span>
   <span class="font10">handle </span>
   <span class="font10">high </span>
   <span class="font10">impurities </span>
   <span class="font10">incident, </span>
   <span class="font10">is, </span>
   <span class="font10">issues, </span>
   <span class="font10">known </span>
   <span class="font10">line </span>
   <span class="font10">majority </span>
   <span class="font10">manage </span>
   <span class="font10">measures, </span>
   <span class="font10">members </span>
   <span class="font10">might </span>
   <span class="font10">objective </span>
   <span class="font10">offers </span>
   <span class="font10">ongoing </span>
   <span class="font10">order </span>
   <span class="font10">over </span>
   <span class="font10">patients </span>
   <span class="font10">per </span>
   <span class="font10">point </span>
   <span class="font10">protecting </span>
   <span class="font10">provides </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapidly </span>
   <span class="font10">recommendation </span>
   <span class="font10">research </span>
   <span class="font10">responsibilities </span>
   <span class="font10">reviewing </span>
   <span class="font10">revised </span>
   <span class="font10">robust </span>
   <span class="font10">roles </span>
   <span class="font10">safety, </span>
   <span class="font10">shared </span>
   <span class="font10">significantly </span>
   <span class="font10">they </span>
   <span class="font10">throughout </span>
   <span class="font10">time </span>
   <span class="font10">tools </span>
   <span class="font10">whether </span>
  </p>
 </body>
</html>
